Boxer Capital as of Dec. 31, 2017
Portfolio Holdings for Boxer Capital
Boxer Capital holds 26 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Avexis | 16.7 | $91M | 825k | 110.67 | |
| Odonate Therapeutics Ord | 12.5 | $68M | 2.7M | 25.00 | |
| Beigene (BGNE) | 10.7 | $59M | 600k | 97.72 | |
| Esperion Therapeutics (ESPR) | 9.6 | $53M | 800k | 65.84 | |
| Macrogenics (MGNX) | 7.6 | $42M | 2.2M | 19.00 | |
| Ptc Therapeutics I (PTCT) | 5.3 | $29M | 1.8M | 16.68 | |
| Mirati Therapeutics | 4.6 | $25M | 1.4M | 18.25 | |
| Ionis Pharmaceuticals (IONS) | 4.1 | $23M | 450k | 50.30 | |
| Medicines Company | 3.8 | $21M | 750k | 27.34 | |
| Wave Life Sciences (WVE) | 3.5 | $19M | 550k | 35.10 | |
| Blueprint Medicines (BPMC) | 3.5 | $19M | 250k | 75.41 | |
| Kura Oncology (KURA) | 2.4 | $13M | 845k | 15.30 | |
| G1 Therapeutics (GTHX) | 2.3 | $13M | 629k | 19.84 | |
| Rigel Pharmaceuticals (RIGL) | 2.2 | $12M | 3.1M | 3.88 | |
| Concert Pharmaceuticals I equity | 1.9 | $10M | 400k | 25.87 | |
| Cymabay Therapeutics | 1.7 | $9.3M | 1.0M | 9.20 | |
| La Jolla Pharmaceuticl Com Par | 1.6 | $8.6M | 268k | 32.18 | |
| Gtx Inc Del | 1.3 | $7.2M | 565k | 12.71 | |
| Aradigm | 1.2 | $6.7M | 1.0M | 6.70 | |
| Sunesis Pharmaceuticals Inc Ne | 0.9 | $4.9M | 1.3M | 3.69 | |
| Bellerophon Therapeutics | 0.9 | $4.8M | 1.9M | 2.58 | |
| Aquinox Pharmaceuticals | 0.7 | $3.7M | 313k | 11.76 | |
| Inotek Pharmaceuticals | 0.5 | $2.6M | 1.0M | 2.61 | |
| Regulus Therapeutics | 0.4 | $2.3M | 2.2M | 1.04 | |
| Syndax Pharmaceuticals (SNDX) | 0.2 | $876k | 100k | 8.76 | |
| Onconova Therapeutics Inc *w exp 07/07/202 | 0.0 | $133k | 242k | 0.55 |
